Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis

INTRODUCTION: Etravirine has become an alternative in HIV/HCV coinfected patients because of safety and lack of interactions with anti-HCV drugs. The aim of this study was to establish the risk of liver toxicity in HIV/HCV coinfected patients receiving etravirine in the clinical setting, according t...

Descripción completa

Detalles Bibliográficos
Autores principales: Luis Casado, Jose, Mena, Alvaro, Bañón, Sara, Moreno, Ana, Castro, Angeles, Perez-Elías, María J, Pedreira, JD, Moreno, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P042
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224832/
https://www.ncbi.nlm.nih.gov/pubmed/25394081
http://dx.doi.org/10.7448/IAS.17.4.19574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224832/
https://www.ncbi.nlm.nih.gov/pubmed/25394081
http://dx.doi.org/10.7448/IAS.17.4.19574

Ejemplares similares